Edwards Lifesciences (EW) Profit After Tax (2009 - 2026)

Edwards Lifesciences has reported Profit After Tax for 18 years, with the latest figure at $380.7 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 4.7% year-over-year to $380.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 73.89% YoY), and the FY2025 full-year result was $1.1 billion, down 23.4% from the prior year.
• Profit After Tax for Q1 2026 stood at $380.7 million, up from $87.1 million in the prior quarter.
• The five-year high for Profit After Tax was $3.1 billion in Q3 2024, with the low at $87.1 million in Q4 2025.
• Average Profit After Tax over 5 years is $489.1 million, with a median of $351.0 million recorded in 2024.
• Year-over-year, Profit After Tax soared 700.31% in 2024 and slumped 90.46% in 2025.
• Tracing EW's Profit After Tax over 5 years: stood at $200.5 million in 2022, then soared by 66.13% to $333.1 million in 2023, then gained by 15.37% to $384.3 million in 2024, then plunged by 77.34% to $87.1 million in 2025, then surged by 337.08% to $380.7 million in 2026.
• The last three Profit After Tax figures came in at $380.7 million (Q1 2026), $87.1 million (Q4 2025), and $293.1 million (Q3 2025), per Business Quant data.

Peer Comparison